ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 8 filers reported holding ODONATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $0 | -100.0% | 299 | -95.0% | 0.00% | – |
| Q2 2021 | $21,000 | 0.0% | 6,033 | -1.2% | 0.00% | – |
| Q1 2021 | $21,000 | +133.3% | 6,108 | +1323.8% | 0.00% | – |
| Q4 2020 | $9,000 | -87.0% | 429 | -91.6% | 0.00% | – |
| Q3 2020 | $69,000 | -75.6% | 5,111 | -23.4% | 0.00% | – |
| Q2 2020 | $283,000 | +24.1% | 6,676 | -19.3% | 0.00% | – |
| Q1 2020 | $228,000 | -58.9% | 8,274 | -51.6% | 0.00% | – |
| Q4 2019 | $555,000 | +109.4% | 17,100 | +67.9% | 0.00% | – |
| Q3 2019 | $265,000 | +314.1% | 10,185 | +481.7% | 0.00% | – |
| Q2 2019 | $64,000 | +481.8% | 1,751 | +241.3% | 0.00% | – |
| Q1 2019 | $11,000 | -72.5% | 513 | -82.1% | 0.00% | – |
| Q4 2018 | $40,000 | +25.0% | 2,867 | +75.8% | 0.00% | – |
| Q3 2018 | $32,000 | +68.4% | 1,631 | +88.6% | 0.00% | – |
| Q2 2018 | $19,000 | – | 865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 14,075,269 | $595,947,000 | 57.94% |
| Samsara BioCapital, LLC | 496,505 | $21,022,000 | 6.76% |
| Boxer Capital, LLC | 3,363,377 | $142,405,000 | 6.26% |
| Opaleye Management Inc. | 250,000 | $10,585,000 | 2.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 785,913 | $33,276,000 | 0.81% |
| RTW INVESTMENTS, LP | 481,027 | $20,367,000 | 0.57% |
| Birchview Capital, LP | 20,000 | $847,000 | 0.51% |
| Rock Springs Capital Management LP | 437,231 | $18,512,000 | 0.51% |
| Redmile Group, LLC | 633,038 | $26,803,000 | 0.50% |
| SABBY MANAGEMENT, LLC | 40,500 | $1,715,000 | 0.34% |